The USPTO granted patent US12588914B2 to Arthrex, Inc. for a meniscal allograft transplantation system and methods of use. The patent, filed as application 18757774, contains 20 claims covering the transplant system and related surgical techniques for meniscal repair. Key CPC classifications include A61B 17/1635 and A61F 2/3872.

Companies developing competing meniscal repair or replacement products should assess freedom-to-operate considerations and monitor the patent landscape. The patent grant does not impose regulatory compliance obligations but may affect competitive dynamics in the orthobiologic medical device space.